A human trial to evaluate the efficacy and safety of Gynostemma pentaphyllum (Thunb.) Makino leaf extract powder on improvement of exercise performance

A human trial to evaluate the efficacy and safety of Gynostemma pentaphyllum (Thunb.) Makino leaf extract powder on improvement of exercise performance - A human trial to evaluate the efficacy and safety of Gynostemma pentaphyllum (Thunb.) Makino leaf extract powder on improvement of exercise performance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044104

Enrollment

100

Registered

2021-05-04

Start date

2020-02-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Gynostemma pentaphyllum (Thunb.) Makino leaf extract powder group: 2 capsules once daily, after breakfast for 12 weeks{700 mg/day, 450 mg/day for Gynostemma pentaphyllum (Thunb.) Makino leaf extract p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adult males and females aged 19 to 60 at the screening test 2) Persons who have agreed to exercise test

Exclusion criteria

Exclusion criteria: 1) Participants who have problems in results about exercise test 2) Participants who have Body Mass Index(BMI) less than 18.5 kg/m^2 or more than 35 kg/m^2 3) Participants who have taken medication or dietary supplements related to the improvement of exercise performance within 3 months prior to screening 4) Participants who have participated in the other human trials within 3 months before the screening test 5) Participants who are judged by the investigator to be ineligible to participate in the study due to other reasons including the results of laboratory test

Design outcomes

Primary

Measure	Time frame
Blood index related to exercise performance	—

Countries

Asia(except Japan)

Contacts

Public ContactKYUNGLIM JOA

Inha University Hospital Department of Rehabilitation Medicine

drjoakl@gmail.com820328902480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026